JC-D7 |
1MG |
1036271-54-1 |
Tildacerfont |
Tildacerfont |
1014983-00-6 |
FIN56 |
FIN56 |
1083162-61-1 |
N-(4-chlorophenyl)-2-(3,5-diMethyl-1H-pyrazol-1-yl)-9-Methyl-9H-purin-6-aMine |
N-(4-氯苯基)-2-(3,5-二甲基-1H-吡唑-1-基)-9-甲基-9H-嘌呤-6-胺 |
1063331-94-1 |
R-121,919 |
3-(6-(二甲基氨基)-4-甲基吡啶-3-基)-2,5-二甲基-N,N-二丙基吡唑并[1,5-A]嘧啶-7-胺 |
195055-03-9 |
CRT5 |
CRT5 |
1034297-58-9 |
BMS-199264 HYDROCHLORIDE |
BMS-199264 HYDROCHLORIDE |
186180-83-6 |
N-[(1R)-1-[[[[4-[[(Aminocarbonyl)amino]methyl]phenyl]methyl]amino]carbonyl]-4-[(aminoiminomethyl)amino]butyl]-α-phenyl-benzeneacetamideditrifluoroacetate |
N-[(1R)-1-[[[[4-[[(Aminocarbonyl)amino]methyl]phenyl]methyl]amino]carbonyl]-4-[(aminoiminomethyl)amino]butyl]-α-phenyl-benzeneacetamideditrifluoroacetate |
191868-14-1 |
Ras/Rac Transformation Blocker, SCH 51344 |
SCH 51344 |
171927-40-5 |
4-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]isoxazolidine-3,5-dione |
4-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]isoxazolidine-3,5-dione |
170861-63-9 |
BMS453 |
BMS453 |
166977-43-1 |
Lu 28-179 |
Lu 28-179 |
163630-79-3 |
2H-Benzimidazole, 2,2-dimethyl-5-nitro-, 1,3-dioxide |
化合物SEPIN-1 |
163126-81-6 |
SR 11302 |
SR 11302 |
160162-42-5 |
(4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one |
(4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one |
158493-17-5 |
(+/-)-TROPANYL 2-(4-CHLOROPHENOXY)BUTANOATE MALEATE |
(+/-)-TROPANYL 2-(4-CHLOROPHENOXY)BUTANOATE MALEATE |
155058-71-2 |
NALFURAFINE |
纳呋拉啡 |
152657-84-6 |
imidazenil |
米达西尼 |
151271-08-8 |
Flavopiridol |
2-(2-氯苯基)-5,7-二羟基-8-[(3S,4R)-3-羟基-1-甲基-4-哌啶基]苯并吡喃-4-酮 |
146426-40-6 |
YM 26734 |
YM 26734 |
144337-18-8 |